Latest Announcements

BSE & NSE corporate filings with AI summaries

BSECompany UpdateResults2 Nov 2026

Cineline India Ltd

Statement of Deviation or Variation for the quarter ended 30th September, 2026.

Cineline India Ltd has submitted a statement of deviation or variation for the quarter ended September 30, 2026, under Regulation 32(1) of the SEBI Listing Regulations. The company confirms that there is no deviation or variation in the utilization of proceeds raised through the allotment of 38,46,153 equity shares upon conversion/exchange of warrants. A NIL statement of deviation or variation is enclosed with the letter.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults2 Nov 2026

VRL Logistics Ltd

Corporate presentation updates as on date.

VRL Logistics Ltd has announced its Q2 FY27 and H1 FY27 financial results, showing a 20% Q2 YoY and 19% H1 YoY revenue growth, with EBITDA and PAT increasing by 43% and 106% Q2 YoY, and 32% and 84% H1 YoY respectively. The company has also announced an equity buyback of ₹280 Cr.

Read more →📎 1 attachment
NSEOutcome of Board MeetingResults2 Nov 2026

BirlaNu Limited

Outcome of Board Meeting

BirlaNu Limited has submitted its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, and announced the incorporation of a wholly-owned subsidiary.

Read more →📎 1 attachment
NSEGeneral UpdatesResults2 Nov 2026

Fine Organic Industries Limited

General Updates

Fine Organic Industries Limited has informed the Exchange about the outcome of its Board meeting, where the Board approved the unaudited financial results for the quarter and half year ended September 30, 2026, and also approved an increase in investment in its subsidiary Fine Organic Industries (SEZ) Private Limited by Rs.120 crores.

Read more →📎 1 attachment
BSECompany UpdateResults2 Nov 2026

Fine Organic Industries Ltd

As enclosed

Fine Organic Industries Ltd announced its unaudited financial results for the quarter and half year ended September 30, 2026. The company's Board of Directors approved an increase in the investment limit in Fine Organic Industries (SEZ) Private Limited by Rs.120 crores, increasing the overall investment from Rs. 300 crores to Rs. 420 crores. The company also submitted a Limited Review Report by its Statutory Auditors, M/s. CNK & Associates LLP, on the unaudited financial results.

Read more →📎 1 attachment
BSEResultResults2 Nov 2026

Advance Metering Technology Ltd

As Attached.

Advance Metering Technology Ltd has announced its un-audited financial results for the second quarter and half year ended September 30, 2026, along with a limited review report. The results will be published in newspapers as per SEBI regulations.

Read more →📎 1 attachment
BSECompany UpdateResults2 Nov 2026

Sagar Cements Ltd-$

Please refer to the letter attached

Sagar Cements Ltd has furnished the audio recording of an analyst/investor meet held to discuss the company's un-audited standalone and consolidated financial results for the second quarter and half year ended 30th September 2026.

Read more →📎 1 attachment
NSEAnalysts/Institutional Investor Meet/Con. Call UpdatesResults2 Nov 2026

20 Microns Limited

Analysts/Institutional Investor Meet/Con. Call Updates

20 Microns Limited has submitted the transcript of its Q2 and H1 FY27 earnings conference call, where the management discussed the company's business and strategy, highlighting revenue growth and gross margin improvement due to a richer product mix.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults2 Nov 2026

Granules India Ltd-$

Press Release

Granules India Ltd. announced its unaudited financial results for Q2FY27, with revenue from operations at INR 15,600 Mn, up 20% YoY, EBITDA at INR 3,376 Mn, up 21% YoY, and PAT at INR 1,818 Mn, up 39% YoY. The company also filed two potential first-to-file ANDAs in H1 and has a net cash position of ₹8,280 million.

Read more →📎 1 attachment
BSECorp. ActionResults2 Nov 2026

IRB Infrastructure Developers Ltd

Record date for the purpose of 2nd Interim Dividend , if declared, by the Board of Directors will be November 12, 2026.

IRB Infrastructure Developers Ltd has announced that its Board of Directors will meet on November 5, 2026, to consider the company's unaudited financial results for the quarter and six months ended September 30, 2026, and to declare a 2nd Interim Dividend for the financial year 2026-27, if any. The record date for the dividend, if declared, will be November 12, 2026.

Read more →📎 1 attachment
BSEBoard MeetingResults2 Nov 2026

Birlanu Ltd

Outcome of Board meeting

Birlanu Ltd's board meeting outcome announced financial results for Q2FY27, incorporated a wholly-owned subsidiary, and received a limited review report from B S Rand Co. The company's unaudited standalone financial results for Q2FY27 and year-to-date results for the period from April 1, 2026, to September 30, 2026, were considered and approved.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults2 Nov 2026

Wockhardt Ltd

Please refer the attachment.

Wockhardt Ltd reported its Q2 FY27 financial results, with revenue growth of 24% compared to the previous year, and EBITDA of Rs.165 Cr compared to Rs.160 Cr in the previous year. The company's Biotech operations recorded a growth of 68% vs Q2 FY26, driven by Emerging Market biotech segment growing at ~110% in H1 FY27.

Read more →📎 1 attachment
BSEBoard MeetingResults2 Nov 2026

Remi Edelstahl Tubulars Ltd

Remi Edelstahl Tubulars Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2026 ,inter alia, to consider and approve the Unaudited Financial Results for the quarter ended 30th September, 2026

Remi Edelstahl Tubulars Ltd will hold a board meeting on 06/11/2026 to consider and take on record the unaudited financial results for the quarter ended 30th September, 2026.

Read more →📎 1 attachment
NSEPress Release▲ PositiveResults2 Nov 2026

Wockhardt Limited

Press Release

Wockhardt Limited reported its Q2 FY27 results, with revenue growth of 24% YoY to Rs.969 Cr, EBITDA growth of 3% YoY to Rs.165 Cr, and PAT of Rs.73 Cr. The company's biotech operations recorded a growth of 68% YoY in Q2 FY27 and 87% YoY in H1 FY27. The company's India branded business grew by 8% YoY in Q2 FY27 and 14% YoY in H1 FY27.

Read more →📎 1 attachment
← PreviousPage 1021 of 4511Next →